CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Los Angeles, California, United States and 44 other locations
blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...
Phase 2
Pasadena, California, United States and 26 other locations
The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...
Phase 3
Northridge, California, United States and 6 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Riverside, California, United States and 24 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Los Angeles, California, United States and 89 other locations
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 day...
Phase 3
Los Angeles, California, United States and 87 other locations
This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...
Phase 2
Long Beach, California, United States and 45 other locations
Patients with diabetic macular edema (DME) sometimes must undergo vitrectomy surgery (PPV) for diabetic and non-diabetic r...
Phase 4
Fullerton, California, United States
The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...
Phase 3
Newport Beach, California, United States and 59 other locations
This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus....
Phase 3
Inglewood, California, United States and 42 other locations
Clinical trials
Research sites
Resources
Legal